Primary hyperfibrinolysis: Facts and fancies

Massimo Franchini, Pier Mannuccio Mannucci

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

Fibrinolysis is a complex process that controls both hemostasis and thrombosis. The regulation of the fibrinolytic system is mediated through a wide array of cofactors and inhibitors that maintain the hemostatic balance in a delicate equilibrium. As a consequence, disturbances in the fibrinolysis pathway are associated with various disease states, ranging from thrombotic to hemorrhagic clinical phenotypes. In particular, a number of inherited and acquired disorders are associated with an enhanced fibrinolysis leading to a bleeding tendency that in some cases may be life-threatening. Hyperfibrinolysis has been classified into primary and secondary forms but such differentiation, which may have important treatment implications, is still controversial. This narrative review will be focused on inherited and acquired conditions associated with primary hyperfibrinolysis.

Original languageEnglish
Pages (from-to)71-75
Number of pages5
JournalThrombosis Research
Volume166
DOIs
Publication statusPublished - Jun 1 2018

Fingerprint

Fibrinolysis
Hemostatics
Hemostasis
Thrombosis
Hemorrhage
Phenotype

Keywords

  • Acquired
  • Antifibrinolytics
  • Bleeding
  • Inherited
  • Primary hyperfibrinolysis

ASJC Scopus subject areas

  • Hematology

Cite this

Primary hyperfibrinolysis : Facts and fancies. / Franchini, Massimo; Mannucci, Pier Mannuccio.

In: Thrombosis Research, Vol. 166, 01.06.2018, p. 71-75.

Research output: Contribution to journalReview article

@article{7099f525c9bb431dbc3b5e1500c2d4c3,
title = "Primary hyperfibrinolysis: Facts and fancies",
abstract = "Fibrinolysis is a complex process that controls both hemostasis and thrombosis. The regulation of the fibrinolytic system is mediated through a wide array of cofactors and inhibitors that maintain the hemostatic balance in a delicate equilibrium. As a consequence, disturbances in the fibrinolysis pathway are associated with various disease states, ranging from thrombotic to hemorrhagic clinical phenotypes. In particular, a number of inherited and acquired disorders are associated with an enhanced fibrinolysis leading to a bleeding tendency that in some cases may be life-threatening. Hyperfibrinolysis has been classified into primary and secondary forms but such differentiation, which may have important treatment implications, is still controversial. This narrative review will be focused on inherited and acquired conditions associated with primary hyperfibrinolysis.",
keywords = "Acquired, Antifibrinolytics, Bleeding, Inherited, Primary hyperfibrinolysis",
author = "Massimo Franchini and Mannucci, {Pier Mannuccio}",
year = "2018",
month = "6",
day = "1",
doi = "10.1016/j.thromres.2018.04.010",
language = "English",
volume = "166",
pages = "71--75",
journal = "Thrombosis Research",
issn = "0049-3848",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Primary hyperfibrinolysis

T2 - Facts and fancies

AU - Franchini, Massimo

AU - Mannucci, Pier Mannuccio

PY - 2018/6/1

Y1 - 2018/6/1

N2 - Fibrinolysis is a complex process that controls both hemostasis and thrombosis. The regulation of the fibrinolytic system is mediated through a wide array of cofactors and inhibitors that maintain the hemostatic balance in a delicate equilibrium. As a consequence, disturbances in the fibrinolysis pathway are associated with various disease states, ranging from thrombotic to hemorrhagic clinical phenotypes. In particular, a number of inherited and acquired disorders are associated with an enhanced fibrinolysis leading to a bleeding tendency that in some cases may be life-threatening. Hyperfibrinolysis has been classified into primary and secondary forms but such differentiation, which may have important treatment implications, is still controversial. This narrative review will be focused on inherited and acquired conditions associated with primary hyperfibrinolysis.

AB - Fibrinolysis is a complex process that controls both hemostasis and thrombosis. The regulation of the fibrinolytic system is mediated through a wide array of cofactors and inhibitors that maintain the hemostatic balance in a delicate equilibrium. As a consequence, disturbances in the fibrinolysis pathway are associated with various disease states, ranging from thrombotic to hemorrhagic clinical phenotypes. In particular, a number of inherited and acquired disorders are associated with an enhanced fibrinolysis leading to a bleeding tendency that in some cases may be life-threatening. Hyperfibrinolysis has been classified into primary and secondary forms but such differentiation, which may have important treatment implications, is still controversial. This narrative review will be focused on inherited and acquired conditions associated with primary hyperfibrinolysis.

KW - Acquired

KW - Antifibrinolytics

KW - Bleeding

KW - Inherited

KW - Primary hyperfibrinolysis

UR - http://www.scopus.com/inward/record.url?scp=85045537809&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85045537809&partnerID=8YFLogxK

U2 - 10.1016/j.thromres.2018.04.010

DO - 10.1016/j.thromres.2018.04.010

M3 - Review article

C2 - 29665524

AN - SCOPUS:85045537809

VL - 166

SP - 71

EP - 75

JO - Thrombosis Research

JF - Thrombosis Research

SN - 0049-3848

ER -